Miranda P. Dierselhuis

Utrecht, UT 3584CS, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

Updated Dutch 2026 pediatric differentiated thyroid carcinoma guideline: aligning with Europe.

Updated Dutch 2026 pediatric differentiated thyroid carcinoma guideline: aligning with Europe.

Journal: European journal of endocrinology
Published: April 12, 2026

Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma.

Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma.

Journal: JCO precision oncology
Published: March 12, 2026

Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk.

Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk.

Journal: Cancers
Published: December 08, 2025

Pituitary dysfunction in childhood after [177Lu]Lu-DOTATATE therapy.

Pituitary dysfunction in childhood after [177Lu]Lu-DOTATATE therapy.

Journal: Journal of pediatric endocrinology & metabolism : JPEM
Published: July 27, 2025

Bone marrow evaluation in neuroblastomas: bone marrow aspirates have little additional value over trephine biopsies.

Bone marrow evaluation in neuroblastomas: bone marrow aspirates have little additional value over trephine biopsies.

Journal: BJC reports
Published: May 06, 2025

Corrigendum to "Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325].

Corrigendum to "Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325].

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 13, 2025

Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer.

Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer.

Journal: ESMO open
Published: April 03, 2025

Urinary Catecholamines Predict Relapse During Complete Remission in High-Risk Neuroblastoma.

Urinary Catecholamines Predict Relapse During Complete Remission in High-Risk Neuroblastoma.

Journal: JCO precision oncology
Published: February 21, 2025

Appendiceal neuroendocrine tumors in children and adolescents: The European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) diagnostic and therapeutic recommendations.

Appendiceal neuroendocrine tumors in children and adolescents: The European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) diagnostic and therapeutic recommendations.

Journal: Surgery
Published: February 03, 2025

PEGylated Granulocyte Colony-Stimulating Factor and Plerixafor Enhance Autologous Stem and Progenitor Cell Mobilization and Transplantation in Pediatric Patients.

PEGylated Granulocyte Colony-Stimulating Factor and Plerixafor Enhance Autologous Stem and Progenitor Cell Mobilization and Transplantation in Pediatric Patients.

Journal: Stem cells and development
Published: January 16, 2025

Prognostic Value of Molecular Aberrations in Low- or Intermediate-Risk Neuroblastomas: A Systematic Review.

Prognostic Value of Molecular Aberrations in Low- or Intermediate-Risk Neuroblastomas: A Systematic Review.

Journal: Cancers
Published: November 01, 2024

Nonthyroidal Illness Syndrome in a Noncritically Ill Child.

Nonthyroidal Illness Syndrome in a Noncritically Ill Child.

Journal: Pediatrics
Published: October 23, 2024
Showing 1-12 of 44

Last Updated: 09/26/2026